The effect of music therapy in the reduction of fatigue of the patients undergoing bone marrow transplantatio
Phase 1
Recruiting
- Conditions
- multiple myeloma.C04.557.595.500
- Registration Number
- RBR-3h4csb
- Lead Sponsor
- Hospital Erasto Gaertner
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients submitted to autologous hematopoietic stem cell transplantation over the age of 18 years.
Exclusion Criteria
All the people that not relize transplant autologous
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measure of fatigue before musical intervention<br>;secondary outcome measure of fatigue after musical intervention
- Secondary Outcome Measures
Name Time Method Tertiary outcome sum of the score of the 22 items of the scale that varies from 0 to 10 if it is greater than 21 there is fatigue if it is smaller there is no fatigue
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie music therapy's impact on fatigue in hematopoietic stem cell transplant recipients with multiple myeloma?
How does music therapy compare to pharmacological interventions in managing fatigue during autologous hematopoietic stem cell transplantation?
Are there specific biomarkers that predict response to music therapy in patients with C04.557.595.500 undergoing bone marrow transplantation?
What adverse events are associated with music therapy in the context of multiple myeloma treatment and how are they managed?
What combination therapies show promise alongside music therapy for fatigue reduction in hematopoietic stem cell transplant patients with multiple myeloma?